BE CAREFUL … PREVAGEN IS CAPABLE OF KILLING YOU.

Presented by Chris J. Lanet author of the Barnacle Zone

In essence, the disclaimer on the box, in its convoluted fashion, said that Prevagen is worthless.

• Note: There are no documented or confirmed medical cases of anyone dying as a direct result of taking Prevagen. However, the supplement has been subjected to severe safety investigations by the U.S. Food and Drug Administration (FDA) due to thousands of reported adverse health reaction. A major lawsuit involves individuals who argue they suffered permanent neurological damage, severe strokes, and seizures after starting a regular Prevagen routine.

  ________________

  Prevagen is an incredibly clever, brilliantly marketed business machine, but as a medical solution, it is a total waste of your money. It is an intriguing case study of how a micky-mouse biotechnology startup turned a jellyfish protein into a multi-million-dollar supplement empire, all while triggering over a decade of intense legal battles with federal regulators. Behind the noise is James R. Moyer, Jr., a neuroscience expert, who claimed that the lowly bioluminescent jellyfish Aequorea Victoria can protect aging neurons in the human brain.

  Neurons are the fundamental information-processing units and communication cells of your nervous system. Because neurons are highly specialized and sensitive, any structural damage or signaling failure causes distinct neurological symptoms depending on where the breakdown occurs. The major claim behind Prevagen is to improve memory and support sharper thinking. From a medical and scientific perspective, Prevagen does not work because it fails two massive biological hurdles: gastric digestion and the blood-brain barrier.

  The core ingredient in Prevagen is apoaequorin, which is a protein. When you swallow any protein—whether it is a piece of steak, an egg, or a Prevagen capsule—your stomach acid and digestive enzymes (like pepsin) immediately go to work. They aggressively break down that complex protein into its basic, microscopic building blocks: amino acids. The intact jellyfish protein is entirely destroyed in your gut long before it can reach your bloodstream. Ironically, the manufacturer’s own safety data proved this. They demonstrated that the protein is safely digested in minutes, which means your body treats a $50 bottle of Prevagen exactly like a few bites of ordinary food.

  A second issue – the product cannot enter the brain. Even if a microscopic amount of the protein somehow survived your stomach acid and slipped into your bloodstream, it faces another roadblock. Your brain is protected by a highly strict security wall called the blood-brain barrier. This barrier only allows exceptionally small molecules (like glucose or water) to pass through from your blood into your brain tissue.  Apoaequorin is a very large, bulky molecule. Independent neuroscience reviews note there is absolutely zero evidence that this protein can cross the blood-brain barrier. Because it cannot enter the brain, it is physically impossible for the supplement to interact with your neurons or regulate their calcium levels as advertised.

  Moreover, when independent researchers tracked more than 200 adults over 90 days, the group taking the real Prevagen pill showed no statistically significant cognitive improvement over the group taking a completely fake sugar pill. If users experience a sense of mental sharpness while taking it, experts attribute it entirely to the placebo effect—the psychological boost that comes from the daily routine of taking an expensive pill you expect to work.

  Launch in 2007 with fake jellyfish juice, saving the harvesting millions of jellyfish—which would require hundreds of pounds of raw jellyfish per capsule— Prevagen was marketed like a house on fire. The infomercial boom (2008–2015) driven by millions of dollars in aggressive television ad campaigns, Prevagen quickly became a household name. Commercials featuring charts, graphs, and actors dressed as doctors heavily targeted aging baby boomers. The ads claimed the supplement was "clinically shown" to improve memory within 90 days. By 2015, Prevagen had exploded into a massive commercial juggernaut, surpassing $165 million in sales. It secured shelf space in over 60,000 major retail locations nationwide, including Walgreens, CVS, and Walmart. Along the way, federal and state cops were on like a red rash. As sales skyrocketed, the product drew intense scrutiny from health and consumer protection agencies to finally caused the FDA to issue a warning letter that barked that Prevagen was marketing the product to treat serious illnesses like Alzheimer's disease and head injuries, and must be regulated as a drug, not a dietary supplement. The FDA also noted that the company had failed to report nearly 1,000 adverse event complaints from consumers, including episodes of chest pain and seizures.

  Also in 2017, the FTC and NY Attorney General  filed a massive lawsuit against Quincy Bioscience. They alleged that the company's "clinically shown" memory claims were deceptive and mathematically flawed. Regulators revealed that Prevagen’s internal study actually showed no overall benefit to the participants' memory, and  had only highlighted a small "subgroup" after the study was over to make the results look positive.

  So what – Micky likes it!

  By 2020, Quincy Bioscience temporarily settled parts of the litigation by agreeing to add a highly specific, court-approved disclaimer to their packaging. The box began stating that its memory claims were based on a study of subgroups of individuals—a detail most average consumers did not understand. In essence, the disclaimer, in its convoluted fashion, said that Prevagen is worthless. 

  In essence, the disclaimer on the box, in its convoluted

  fashion, said that Prevagen is worthless.

  Meanwhile, sales increased and multi-millions of dollars later, a Final Jury Verdict in 2024 found Quincy Bioscience liable for deceptive acts, false advertising, and repeated fraud.

  By late 2024, a federal court officially ordered the makers of Prevagen to cease making their hallmark claims. The company was legally forbidden from advertising that the supplement is "clinically proven" to improve memory, or that it shows results within 90 days, severely altering how the product could be marketed.

  Following a December 2024 federal court injunction prohibiting explicit memory-improvement and "clinically proven" claims, Quincy Bioscience adjusted its marketing strategy for Prevagen. The company adopted generalized slogans like "For Your Brain," transitioned to FDA-compliant structure-function claims, relied on established brand recognition, and appealed the court's decision.

  Despite a sweeping ban on their core memory claims, Quincy Bioscience found legal loopholes to keep Prevagen on the shelves of major retailers like CVS and Walgreens. They fundamentally overhauled their presentation through specific tactical shifts:

  The Vague Tagline Shift: In early 2025, the company launched an aggressive new ad campaign swapping out "improves memory" for an ambiguous, legally safer phrase: "For Your Brain". They also shifted to labeling Prevagen broadly as a "brain support" supplement.

  Utilizing Structure-Function Loopholes: Under U.S. dietary supplement law, companies cannot claim a product cures or treats a condition (like memory loss), but they can claim it supports a structure or function of the body (e.g., "supports brain health"). Quincy stripped out concrete timeframes (like "90 days") and exact benefits ("sharper memory") and replaced them with generalized, hard-to-disprove wellness claims.

  Scrubbing Digital and Physical Assets: Quincy was forced to quickly execute a massive logistical pivot. They wiped all memory-improvement text off product bottles, updated online storefronts like Amazon, and pulled old TV commercials to avoid compounding contempt-of-court fines.

  Relying on Residual Brand Equity: Because Quincy spent over a decade and hundreds of millions of dollars drilling the name "Prevagen" into the minds of aging consumers, the brand name itself had become synonymous with memory assistance. By keeping the packaging aesthetics identical and simply weakening the text, they continued to capture consumers who already associated the product with brain health.

  The battle didn't stop with the 2024 injunction. Consumer advocacy groups like Truth in Advertising immediately began monitoring the new "For Your Brain" ads, flagging them as potential ongoing violations. Meanwhile, Quincy Bioscience appealed the district court's injunction. The case moved up to the Second Circuit Court of Appeals, where formal oral arguments were heard in February 2026 as the company continues to fight to reclaim its original marketing copy.

  From 2024 through the present, the financial reality of Prevagen and its parent company, Quincy Bioscience, stands in stark contrast to their extensive legal defeats. Despite being hit with sweeping federal bans on their advertising claims, the product remains immensely profitable.

  Sales Figures (2024 to Present.

  Even though federal courts and the Federal Trade Commission (FTC) legally ordered the company to strip its hallmark "clinically proven memory improvement" claims from its boxes and TV spots, sales have remained incredibly resilient.

  The Market Reality: Industry market tracking data shows that Prevagen holds a 3% to 5% share of the total multi-billion-dollar global brain health supplement market.

  Current Revenue: Its annual U.S. retail sales continue to hover at roughly $200+ million annually.

  The "Boomer" Cushion: Financial analysts note that the company is heavily protected by a massive, structurally expanding demographic of aging baby boomers. Because millions of older consumers have been taking the pill for years or see its pervasive new ad campaigns, brand momentum continues to drive massive pharmacy retail volume.

  Despite years of aggressive legal battles, fraud verdicts, and intense media scrutiny, people continue to buy Prevagen in massive numbers. The psychological, structural, and marketing reasons keeping this product on store shelves break down into several distinct factors: (1) Preying on "Age Panic": Cognitive decline—and specifically the fear of developing dementia or Alzheimer's disease—is one of the deepest anxieties for aging adults. When people occasionally forget a name or misplace their keys, it triggers an emotional response. Supplement marketers intentionally tap into this vulnerability. For a worried senior, spending $50 a month on a pill feels like a small price to pay for "insurance" against their worst fear, overriding any clinical data or headlines they might have skipped. (2) The Power of Direct TV Ads Over Internet Headlamps: The target demographic for Prevagen (adults aged 60 to 80+) relies heavily on traditional broadcast network television and national cable news channels. While the internet is flooded with medical warnings and articles detailing the company's legal fraud, that information does not penetrate the media ecosystem where the company spends close to $100 million annually on ads. If a consumer watches thousands of comforting, authoritative commercials over several years, a brief negative news article or an abstract legal settlement rarely reverses that deeply ingrained conditioning. (3) Immediate "Vague Slogan" Pivots: Whenever federal judges or the Federal Trade Commission (FTC) legally block the company from using specific phrases like "clinically proven to improve memory," the company instantly pivots. By rolling out fresh slogans like "Prevagen – For Your Brain," they completely bypass the specific court bans while keeping the exact same premium look and feel. The average person walking into a pharmacy does not realize the box has been forced to change; they just recognize the trusted brand logo from television. (4) Institutional Trust by Placement: People trust where they buy things. Because Prevagen is prominently displayed in major, trusted physical brick-and-mortar pharmacies—such as Walgreens, CVS, and Walmart—consumers automatically assume the product must be safe and legitimate. The average consumer naturally concludes, "If it were total fraud, a major pharmacy chain wouldn't be allowed to sell it on their shelves."  (5)  The Psychological Trap of the Placebo Effect: As noted in clinical studies, the psychological act of taking a premium pill every morning actually tricks the brain into feeling sharper. If a customer takes Prevagen and feels a slight boost in confidence or has a string of "good memory days," they attribute it completely to the pill. This positive reinforcement creates fierce brand loyalty. Even if they hear about a lawsuit, they often think, "Well, the science might be flawed for other people, but I know it's working for me."

  Conclusion:

  The science doesn't work: Biologically, swallowing a jellyfish protein to help your brain makes no sense. The moment that pill hits your stomach, your digestive juices break it down into ordinary amino acids. It never makes it to your bloodstream intact, and it certainly does not cross the blood-brain barrier. You might as well eat a piece of chicken or an egg—your body processes it the exact same way, and it costs a fraction of the price.

  You Are Paying for Commercials, Not Medicine: When a company charges $40 to $90 a bottle for an ingredient that costs less than $5 to manufacture, you have to ask where the rest of that money is going. It isn't going into premium ingredients or groundbreaking research; it is going directly into funding a $100-million-a-year TV advertising blitz. You are effectively paying a massive premium to subsidize the very commercials that convinced you to buy it in the first place.

  The Trust Factor is Gone: When a federal jury and multiple consumer protection agencies flat-out declare your marketing to be fraudulent and deceptive, the debate is pretty much over. Slicing up data from a failed study to trick worried seniors into thinking a pill is a "clinically proven" miracle is highly unethical.

• The solution presented by Chris J. Lanet

  
  

  

  "In the context of longevity, your brain's reward system is not a static machine but a dynamic engine that undergoes chemical and functional shifts as you age. While common aging involves a decline in dopamine, the system is remarkably resilent and adapts through compensatory mechanisms to maintain vitality. You must reinvent your brain by learning how to trigger alertness and active focus. By mastering these events you can stimulate brain efficiency -- key factot in longevity," Chris J. Lanet

  
  

  Okay!  I used hard science and commonsense to prove that Prevagen is a waste of time and money. Even with all the legal controversies and scientific skepticism, people continue to buy Prevagen because it is a masterclass in emotional marketing that perfectly exploits human vulnerability. Besides unstoppable noise of TV marketing and other ploys to keep you consuming the product, the major element is the factor I call “Age Anxiety.”  

  Age Anxiety is the fear of losing independence or developing dementia—

  is one of the deepest anxieties for aging adults.

  There’s a better means than Prevagen and all its counterparts to support the brain and it’s free.   You carry it around on your shoulders – the brain. The most complex biological organ in the known universe, serving as the command center for your entire nervous system. Weighing about three pounds in the average adult and possessing a gelatin-like texture, it interprets the outside world, generates your thoughts, controls your movements, and stores your lifetime of memories.

  Make the brain work for you.

  You need to reinvent your brain as you age. It’s the essential and only means to combat natural cognitive decline, strengthen "cognitive reserve" (the brain’s ability to improvise and find alternate routes to solve problems), and maintain daily functioning. i.e. Mental stimulation—like learning new skills—promote neuroplasticity, allowing the brain to rewire itself, build new connections, and remain resilient against age-related damage.

  The brain controls aging by regulating cognitive speed, memory, and structural changes like cortical thinning and reduced blood flow. It governs neuronal communication, neurochemical production (dopamine/serotonin), and amyloid-beta accumulation, directly impacting cognitive decline, motor functions, and susceptibility to neurodegenerative diseases.

  

  I authored Barnacle Zone, a book about the brain.

  It's a hybrid ensemble that contains a compilation of my original content and material generated with the assistance of artificial intelligence. The selection, coordination, arrangement, and unique expression of all materials within this work are the original creative opus of yours truly, who by remaining alive beyond my expiration date I am the 85-year-old longevity expert with a view of what to do to stay alive that should last me to 100.

  "That's my goal, make it yours"

  
  

  Buy it! Drop the $25.00, crack open the book, and find out who you really are—and how much road you may still have left on planet Earth.

  
  
•